Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)

SHA:688578 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,048	586.99	1,862	470.49	615.36	365.84
Short-Term Investments	210	280	230	-	20	-
Trading Asset Securities	2,735	2,759	419.6	1,567	1,625	2,225
Cash & Short-Term Investments	3,993	3,626	2,512	2,037	2,260	2,591
Cash Growth	35.12%	44.37%	23.29%	-9.86%	-12.78%	173.64%
Accounts Receivable	449.53	389	260.17	150.85	14.83	0.29
Other Receivables	20.69	29.26	29.07	6.82	3.58	2.28
Receivables	470.21	418.26	289.24	157.68	18.42	2.57
Inventory	40.87	30.56	62.95	32.07	20.8	10.78
Prepaid Expenses	-	2.15	3.18	2.5	-	-
Other Current Assets	146.99	103.21	40.79	56.69	75.42	74.69
Total Current Assets	4,651	4,180	2,908	2,286	2,375	2,679
Property, Plant & Equipment	527.84	516.37	526.64	539.94	404.03	206.88
Long-Term Investments	198.89	244.4	145.26	52.73	38.37	20
Other Intangible Assets	181.41	65.38	66.49	68.45	67.29	69.18
Long-Term Deferred Tax Assets	-	0	-	11.5	-	-
Long-Term Deferred Charges	146.32	168.12	0.71	0.57	2.11	2.71
Other Long-Term Assets	1,270	741.45	729.5	482.76	243.79	8.93
Total Assets	6,975	5,916	4,376	3,442	3,130	2,987
Accounts Payable	20.62	27.39	13.25	5.15	1.75	3.44
Accrued Expenses	676.99	482.4	314.33	152.68	96.96	93.58
Current Portion of Leases	1.83	0.99	1.43	1.66	4.72	-
Current Income Taxes Payable	101.35	67.45	5.4	6.98	-	0.36
Current Unearned Revenue	-	-	-	0.1	0.18	-
Other Current Liabilities	19.73	22.37	55.62	88.04	52.51	11.63
Total Current Liabilities	820.52	600.6	390.03	254.62	156.12	109.01
Long-Term Leases	2.03	0.3	0.39	0.3	0.68	-
Long-Term Deferred Tax Liabilities	18.39	28.77	0.14	-	-	-
Other Long-Term Liabilities	3.28	3.65	3.65	0.2	0.2	-
Total Liabilities	844.23	633.32	394.22	255.12	156.99	109.01
Common Stock	450	450	450	450	450	450
Additional Paid-In Capital	3,269	3,254	3,175	3,100	3,031	2,957
Retained Earnings	2,273	1,401	264.02	-380.16	-510.68	-528.95
Comprehensive Income & Other	139.21	177.89	93.63	17.61	3.25	-
Shareholders' Equity	6,131	5,283	3,982	3,187	2,973	2,878
Total Liabilities & Equity	6,975	5,916	4,376	3,442	3,130	2,987
Total Debt	3.87	1.3	1.82	1.96	5.39	-
Net Cash (Debt)	3,989	3,625	2,510	2,035	2,255	2,591
Net Cash Growth	35.05%	44.42%	23.32%	-9.73%	-12.99%	209.60%
Net Cash Per Share	8.87	8.06	5.57	4.52	4.94	7.01
Filing Date Shares Outstanding	450	450	450	450	450	450
Total Common Shares Outstanding	450	450	450	450	450	450
Working Capital	3,830	3,580	2,518	2,032	2,219	2,570
Book Value Per Share	13.62	11.74	8.85	7.08	6.61	6.40
Tangible Book Value	5,950	5,217	3,916	3,119	2,906	2,809
Tangible Book Value Per Share	13.22	11.59	8.70	6.93	6.46	6.24
Buildings	482.82	508.81	494.91	470.35	116.73	116.73
Machinery	204.43	156.45	132.04	140.27	88.34	75.36
Construction In Progress	10.43	5.19	18.58	13.8	266.57	78.44

Source: S&P Global Market Intelligence. Standard template. Financial Sources.